Mariner’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Mariner’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,902	Closed	-$602K	–	3269
2023 Q4	$602K	Sell	1,902 -123	-6%	-$23.9K	﹤0.01%	1818
2023 Q3	$342K	Sell	2,025 -46	-2%	-$8.65K	﹤0.01%	2037
2023 Q2	$449K	Buy	2,071 +479	+30%	+$103K	﹤0.01%	1820
2023 Q1	$289K	Buy	1,592 +363	+30%	+$69.4K	﹤0.01%	2099
2022 Q4	$241K	Buy	+1,229	New	+$264K	﹤0.01%	2212

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Mariner's KRTX Position: Q1 2024 in Review

Mariner sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,902 shares — an estimated $602K sold.

Mariner first reported a position in KRTX in Q4 2022 and held it in 5 quarters. The position peaked at $602K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Mariner reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Mariner sold 1,902 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $602K.
Mariner first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
Mariner's Karuna Therapeutics, Inc. Common Stock position peaked at $602K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Mariner's 13F filing for Q1 2024, filed 15 May 2024.